|

[68Ga]Ga-PentixaFor Clinical Trials

3 actively recruiting trials across 1 location

Also known as: CXCR4

Pipeline

Phase 2: 2

Top Sponsors

  • University Health Network, Toronto1
  • National Cancer Institute (NCI)1
  • Nantes University Hospital1

Indications

  • Cancer3
  • Multiple Myeloma2
  • Cushing s Syndrome1
  • Hyperaldosteronism1
  • Hypercortisolism1

Other2 trials

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)
N/A
Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma
Phase 2

Bethesda, Maryland1 trial

Evaluating the Functional Status of the Adrenal Glands With [68Ga]Ga-PentixaFor in Hyperaldosteronism and Hypercortisolism

National Institutes of Health Clinical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.